Genmab — Juni 2016
-
Jeg har lagt dagens videoer her: http://www.proinvestor.com/?p=debat_1&postid=74794&thread=50&start=#74796
-
Nej, men en enkelt udtalelse tidligere på dagen. MUFC har citeret ham.
-
@martinicph: Hvordan kan du konkludere at den mediane PFS vil ende på lidt over 15 mdr, når grafen viser at efter 15 mdr er halvdelen af patienterne stadig progressionsfrie?
-
-
For dem der ikke kan se FT artikler: http://www.wsj.com/articles/combination-drug-therapies-for-cancer-show-promise-at-higher-potential-cost-1465141936
-
Tak Celetus.
-
Man kan se en artikel dagligt på Financial Times.
-
Så vågner indenlandske medier så småt... http://finans.dk/protected/finans/erhverv/ECE8734436/genmabs-vidundermiddel-leverer-historisk-gode-data/?ctxref=fplive
-
-
@Bulder. Jeg synes blot kurven er meget tæt medianen (omend den er flad), så undlad at se lidt over 15 måneder som en nagelfast konklusion.
Forhåbentlig ender vi højere. -
Novod fra ASCO: "JNJ Partners with Celgene to test Darzalex in combo with PD-L1 checkpoint inhibitor Durvalumab"
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind